Changes of inflammatory factors and adipokines in patients with diabetic osteoporosis
Objective: This study aimed to investigate the changes of inflammatory factors and adipokines in patients with diabetic osteoporosis. Methods: A total of 142 type 2 diabetic patients were divided into osteoporosis group (OP, n=78) and non-osteoporosis group (NOP, n=64) according to the conditions...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2016-03-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.jhmuweb.net/PDF/201605/7.pdf |
Summary: | Objective: This study aimed to investigate the changes of inflammatory factors and adipokines
in patients with diabetic osteoporosis. Methods: A total of 142 type 2 diabetic patients were
divided into osteoporosis group (OP, n=78) and non-osteoporosis group (NOP, n=64) according
to the conditions of bone density. Then levels of blood lipid, inflammatory factors and
adipokines were detected and compared. Results: As for blood lipids, the levels of low density
lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were not
significantly different between the two groups (P>0.05), while the levels of total cholesterol
(TC) and triglyceride (TG) in the OP group were significantly higher than those in the NOP
group (P<0.05); referring to inflammatory factors, the levels of monocyte chemoattractant
protein-1 (MCP-1), hyper-sensitive C-reactive protein (hs-CRP) and tumor necrosis factor-α
(TNF-α) in the OP group were significantly increased compared with the NOP group (P<0.05);
speaking to adipokines, the levels of visceral adipose tissue-derived serine protease inhibitor
(vaspin) and adiponectin rose obviously and the level of visfatin declined apparently in the OP
group compared with the NOP group (P<0.05). Conclusions: The alterations of the levels of
inflammatory factors and adipokines might increase the risk of osteoporosis in patients with
type 2 diabetes mellitus. |
---|---|
ISSN: | 1007-1237 1007-1237 |